Monday, February 9, 2015

Off From Last Year's High -- But Still Very Respectable: BlackRock Holds 6.6% Of Merck At Year End 2014

This still puts Merck near the top of the venerable firm's holdings in the pharma space, by dollar weighting. Here is the morning's full text SEC filing -- on Schedule 13G.

This is reduced from the zenith -- at 7 per cent -- breached last year, this time. But as I say, still respectable. Very. . . respectable:

Here is last year's item on this -- for perspective. Off to enjoy a foggy, London style Monday morning.

No comments: